EP 1242110 A1 20020925 - COMPOSITION FOR TREATING PROSTATE CANCER
Title (en)
COMPOSITION FOR TREATING PROSTATE CANCER
Title (de)
ZUSAMMENSETZUNG ZUR BEHANDLUNG VON PROSTATAKREBS
Title (fr)
COMPOSITION DE TRAITEMENT DU CANCER DE LA PROSTATE
Publication
Application
Priority
- US 0041562 W 20001025
- US 42837599 A 19991028
Abstract (en)
[origin: WO0134176A1] A method of treating prostate cancer in a living mammal includes local administration of a composition that includes a therapeutically effective concentration of collagenase. In one embodiment, a method of treating prostate cancer in a living mammal includes local administration of a composition that includes a therapeutically effective concentration of collagenase and at least one of a glycosidase, a protease, a nuclease, a lipase, an esterase, a plasminogen activator, a streptokinase, and combinations thereof. Preferably a glycosidase, such as, for example, hyaluronidase, is administered. Compositions used in methods for treating prostate cancer can also include or be administered with calcium ions, a nonionic surfactant, such as, for example, Triton3 X-100, and an antibiotic, such as, for example, gentamicin. Another method of treating prostate cancer in a living mammal includes activating PSA <i>in vivo</i> by, for example, locally administering calcium ions.
IPC 1-7
IPC 8 full level
C07H 15/234 (2006.01); A61K 31/7036 (2006.01); A61K 33/06 (2006.01); A61K 38/16 (2006.01); A61K 38/46 (2006.01); A61K 38/48 (2006.01); A61K 38/54 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 13/08 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 33/06 (2013.01 - EP US); A61K 38/164 (2013.01 - EP US); A61K 38/4886 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 13/08 (2017.12 - EP); A61P 35/00 (2017.12 - EP)
Citation (search report)
See references of WO 0134176A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0134176 A1 20010517; AT E373483 T1 20071015; AU 2617901 A 20010606; CA 2389176 A1 20010517; CN 1176714 C 20041124; CN 1384754 A 20021211; DE 60036490 D1 20071031; DE 60036490 T2 20080619; EP 1242110 A1 20020925; EP 1242110 B1 20070919; JP 2003513931 A 20030415; US 2002061300 A1 20020523; US 2002106359 A1 20020808; US 6428785 B1 20020806; US 6913744 B2 20050705
DOCDB simple family (application)
US 0041562 W 20001025; AT 00989699 T 20001025; AU 2617901 A 20001025; CA 2389176 A 20001025; CN 00814920 A 20001025; DE 60036490 T 20001025; EP 00989699 A 20001025; JP 2001536173 A 20001025; US 42837599 A 19991028; US 5506302 A 20020122